Melisa E. Gantner

Citata da

	Tutte	Dal 2019
Citazioni	257	173
Indice H	8	7
i10-index	8	5

2013201420152016201720182019202020212022202320247 9 17 15 22 13 18 16 32 39 38 29

Accesso pubblico

Visualizza tutto

10 articoli

2 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Alan TaleviProfesor de la Facultad de Ciencias Exactas - Universidad Nacional de La PlataEmail verificata su biol.unlp.edu.ar
Dra. María Esperanza RuizProf. Diseño de Experimentos & Control de Calidad de Medicamentos, Universidad Nacional de La PlataEmail verificata su biol.unlp.edu.ar
Luciana GavernetProfesor e investigador de la Facultad de Ciencias Exactas, Universidad Nacional de La PlataEmail verificata su biol.unlp.edu.ar
Carolina L. BelleraProfesora Facultad de Ciencias Exactas, Universidad Nacional de La Plata, LIDeBEmail verificata su biol.unlp.edu.ar
Manuel A. LlanosThe Scripps Research InstituteEmail verificata su scripps.edu
Santiago RodriguezPhD Student, National University of La Plata, ArgentinaEmail verificata su biol.unlp.edu.ar
Mauricio Di IanniUniversidad Nacional de La PlataEmail verificata su biol.unlp.edu.ar
Lucas Nicolás AlbercaUniversidad Nacional de La Plata, Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB)Email verificata su biol.unlp.edu.ar
Eduardo A Castroprofesor de Quimica, Universidad Nacional de La PlataEmail verificata su quimica.unlp.edu.ar
Maria Luisa VillalbaDocente de Química Orgánica .FCE-UNLP/Personal de Apoyo a la Investigación (CONICET)Email verificata su quimica.unlp.edu.ar
Luis Bruno BlanchDoctor en Ciencias Químicas Facultad de Ciencias Exactas UNLPEmail verificata su quimica.unlp.edu.ar
Marcelo CominiPrincipal Investigator, Institut Pasteur de Montevideo, UruguayEmail verificata su pasteur.edu.uy
Pablo PalestroAyudante Diplomado, Universidad Nacional de La PlataEmail verificata su biol.unlp.edu.ar
Juan Francisco MoralesQuantitative Medicine Scientist, Pharmacometrics at Critical Path Institute (C-Path)Email verificata su c-path.org
Federico Mariano GarofaloLic. En Química con orientación en Química Orgánica. Doctor de la Facultad de Ciencias ExactasEmail verificata su quimica.unlp.edu.ar
Daniela VulloDipartimento di Chimica Universita' di FirenzeEmail verificata su unifi.it
Denis Nihuel Prada GoriPostdoctoral fellow at Laboratory of Bioactive Research and Development (LIDeB) of the NationalEmail verificata su biol.unlp.edu.ar
Andrew G. MercaderInvestigador Asitente, INIFTA, CONICET. Prof. Adjunto, Facultad de Ciencias Exactas, UNLPEmail verificata su inifta.unlp.edu.ar
Nelson DuránInstituto de Química, Universidade Estadual de Campinas,Email verificata su iqm.unicamp.br
Guillermo R. CastroNanomedicine Nucleus, Universidade Federal do ABC, SP, BrazilEmail verificata su ufabc.edu.br

Segui

Melisa E. Gantner

Docente investigador, Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB), Facultad de

Email verificata su biol.unlp.edu.ar - Home page

Química Medicinal diseño racional de fármacos cribado virtual modelado molecular docking molecular


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study MA Llanos, ME Gantner, S Rodriguez, LN Alberca, CL Bellera, A Talevi, ... Journal of Chemical Information and Modeling 61 (8), 3758-3770, 2021	49	2021
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems) M E Ruiz, M E Gantner, A Talevi Recent patents on anti-cancer drug discovery 9 (1), 99-128, 2014	39	2014
CNS drug development-lost in translation? A Talevi, C L Bellera, M Di Ianni, M Gantner, L E Bruno-Blanch, ... Mini reviews in medicinal chemistry 12 (10), 959-970, 2012	36	2012
Can drug repurposing strategies be the solution to the COVID-19 crisis? CL Bellera, M Llanos, ME Gantner, S Rodriguez, L Gavernet, M Comini, ... Expert Opinion on Drug Discovery, 2020	31	2020
Applications of nanosystems to anticancer drug therapy (part I. nanogels, nanospheres, nanocapsules) A Talevi, M E Gantner, M E Ruiz Recent patents on anti-cancer drug discovery 9 (1), 83-98, 2014	24	2014
Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates ME Gantner, ME Di Ianni, ME Ruiz, A Talevi, LE Bruno-Blanch BioMed Research International 2013 (1), 863592, 2013	19	2013
Development and validation of a computational model ensemble for the early detection of BCRP/ABCG2 substrates during the drug design stage ME Gantner, RN Peroni, JF Morales, ML Villalba, ME Ruiz, A Talevi Journal of chemical information and modeling 57 (8), 1868-1880, 2017	17	2017
Computer-aided recognition of ABC transporters substrates and its application to the development of new drugs for refractory epilepsy M Couyoupetrou, M E Gantner, M E Di Ianni, P H Palestro, A V Enrique, ... Mini reviews in medicinal chemistry 17 (3), 205-215, 2017	13	2017
Systematic comparison of the performance of different 2d and 3d ligand-based virtual screening methodologies to discover anticonvulsant drugs M E Di Ianni, M E Gantner, M E Ruiz, E A Castro, L E Bruno-Blanch, ... Combinatorial chemistry & high throughput screening 18 (4), 387-398, 2015	5	2015
Identification of New Carbonic Anhydrase VII Inhibitors by Structure-Based Virtual Screening ME Gantner, DN Prada Gori, MA Llanos, A Talevi, A Angeli, D Vullo, ... Journal of Chemical Information and Modeling 62 (19), 4760-4770, 2022	4	2022
Potential biocide roles of violacein I Rivero Berti, ME Gantner, S Rodriguez, GA Islan, WJ Fávaro, A Talevi, ... Front. Nanotechnol. 5 (1186386), 2023	3	2023
Computational and Synthetic Target-based Approaches to the Discovery of Novel Anticonvulsant Compounds. ME Gantner, MA Llanos, FM Garofalo, ML Villalba, L Gavernet Current Medicinal Chemistry 28 (33), 6866-6894, 2021	3	2021
Integrated Application of Enhanced Replacement Method and Ensemble Learning for the Prediction of BCRP/ABCG2 Substrates M E Gantner, L N Alberca, A G Mercader, L E Bruno-Blanch, A Talevia Current Bioinformatics 12 (3), 239-248, 2017	3	2017
Recent advances on nanotechnology applications to cancer drug therapy C Bellera, ME Gantner, ME Ruiz, A Talevi Journal of Cancer Research Updates 2 (3), 151-185, 2013	3	2013
Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules). Recent Pat. Anticancer Drug Discov. 2014; 9 (1): 83–98 A Talevi, ME Gantner, ME Ruiz	3
Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro SM Ruatta, DN Prada Gori, M Fló Díaz, F Lorenzelli, K Perelmuter, ... Frontiers in Pharmacology 14, 1193282, 2023	2	2023
Topología molecular aplicada al reconocimiento de sustratos de la Proteína de Resistencia del Cáncer de Mama (BCRP) ME Gantner Universidad Nacional de La Plata, 2016	2	2016
Discovering New Antiepileptic Drugs Addressing the Transporter Hypothesis of Refractory Epilepsy: Ligand-Based Approximations M Couyoupetrou, M Di Ianni, M Gantner, G Pesce, R Peroni, A Talevi, ... Antiepileptic Drug Discovery, 259-279, 2016	1	2016
Rational design of carbonic anhydrase VII inhibitors. Synthesis of new candidates with the sulfamide scaffold F Garofalo, K Terrazas, L Gavernet, M Gantner MDPI, 2022		2022
Rational design of carbonic anhydrase VII inhibitors FM Garofalo, KA Terrazas, L Gavernet, ME Gantner 8th International Electronic Conference on Medicinal Chemistry (ECMC)(On …, 2022		2022

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori